Philochem AG, Libernstrasse 3, Otelfingen, Switzerland.
Philogen SpA, Monteriggioni, Italy.
Proteomics. 2018 Jun;18(12):e1700246. doi: 10.1002/pmic.201700246. Epub 2018 Mar 14.
The interaction between HLA class II peptide complexes on antigen-presenting cells and CD4 T cells is of fundamental importance for anticancer and antipathogen immunity as well as for the maintenance of immunological tolerance. To study CD4 T cell reactivities, detailed knowledge of the presented peptides is necessary. In recent years, dramatic advances in the characterization of membranal and soluble HLA class I peptidomes could be observed. However, the same is not true for HLA class II peptidomes, where only few studies identify more than hundred peptides. Here we describe a MS-based workflow for the characterization of membranal and soluble HLA class II DR and DQ peptidomes. Using this workflow, we identify a total of 8595 and 3727 HLA class II peptides from Maver-1 and DOHH2 cells, respectively. Based on this data, a motif-based binding predictor is developed and compared to NetMHCIIpan 3.1. We then apply the workflow to human plasma, resulting in the identification of between 34 and 152 HLA-DR and between 100 and 180 HLA-DQ peptides, respectively. Finally, we implement a data-independent acquisition workflow to increase reproducibility and sensitivity of HLA class II peptidome characterizations.
HLA Ⅱ类肽复合物在抗原呈递细胞和 CD4 T 细胞之间的相互作用对于抗肿瘤和抗病原体免疫以及维持免疫耐受至关重要。为了研究 CD4 T 细胞的反应性,需要详细了解所呈递的肽。近年来,在膜和可溶性 HLA Ⅰ类肽组的特征描述方面取得了巨大进展。然而,HLA Ⅱ类肽组并非如此,其中只有少数研究鉴定出超过一百种肽。在这里,我们描述了一种基于 MS 的工作流程,用于表征膜和可溶性 HLA Ⅱ类 DR 和 DQ 肽组。使用此工作流程,我们分别从 Maver-1 和 DOHH2 细胞中鉴定出总共 8595 和 3727 个 HLA Ⅱ类肽。基于此数据,开发了一种基于基序的结合预测器,并与 NetMHCIIpan 3.1 进行了比较。然后,我们将该工作流程应用于人血浆,分别鉴定出 34 到 152 个 HLA-DR 和 100 到 180 个 HLA-DQ 肽。最后,我们实施了一种数据非依赖性采集工作流程,以提高 HLA Ⅱ类肽组特征描述的重现性和灵敏度。